Harvard Bioscience (NASDAQ:HBIO – Get Free Report) will be announcing its earnings results before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.06 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link.
Harvard Bioscience (NASDAQ:HBIO – Get Free Report) last posted its earnings results on Thursday, March 7th. The medical instruments supplier reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). The company had revenue of $28.15 million for the quarter, compared to analysts’ expectations of $27.80 million. Harvard Bioscience had a positive return on equity of 2.75% and a negative net margin of 3.04%.
Harvard Bioscience Stock Up 0.3 %
Harvard Bioscience stock traded up $0.01 during mid-day trading on Tuesday, reaching $3.72. 126,720 shares of the company were exchanged, compared to its average volume of 86,727. The business has a fifty day moving average of $4.21 and a 200 day moving average of $4.47. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.92 and a current ratio of 1.85. The firm has a market cap of $161.45 million, a P/E ratio of -46.37 and a beta of 1.42. Harvard Bioscience has a 12-month low of $3.44 and a 12-month high of $6.29.
Harvard Bioscience Company Profile
Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.
Featured Articles
- Five stocks we like better than Harvard Bioscience
- How to Invest in Insurance Companies: A Guide
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Why Invest in 5G? How to Invest in 5G Stocks
- Hilton Demonstrates Asset Light is Right for Investors
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Harvard Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harvard Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.